Bone evaluation study-2: update on the epidemiology of osteoporosis in Germany

Hadji Peyman,Esterberg Elizabeth,Obermüller Dominik,Bartsch Robert

DOI: https://doi.org/10.1007/s11657-024-01380-9

2024-04-10

Archives of Osteoporosis

Abstract:Osteoporosis is the most common bone disorder. Our data gives an estimate of around 5.87 million cases of osteoporosis in the general German population in 2018. Only 30% of insured individuals who suffered an osteoporotic fracture and/or had a confirmed diagnosis of osteoporosis, received an appropriate prescription.

endocrinology & metabolism,orthopedics

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to evaluate the prevalence of osteoporosis in the German population aged 50 and above, and to collect data on the frequency of prescriptions for osteoporosis - specific drugs in order to assess the treatment gap. Specifically, the study aims to:

1. **Estimate the prevalence of osteoporosis in the German population aged 50 and above**: Determine the prevalence of osteoporosis in this age group by analyzing data in the insurance database.
2. **Evaluate the diagnosis and treatment of osteoporosis**: Pay particular attention to how many people among those who have already had an osteoporotic fracture or been diagnosed with osteoporosis have received appropriate drug treatment.
3. **Identify the influence of gender and age on the prevalence and treatment of osteoporosis**: Analyze the differences between different gender and age groups to understand how these factors affect the diagnosis and treatment of osteoporosis.

### Research Background
Osteoporosis is the most common bone disease, mainly affecting the elderly and increasing the risk of non - traumatic fractures. Multiple studies in Germany and other European countries have shown that the prevalence of osteoporosis is high, but the problem of under - treatment is widespread. For example, the Bone Evaluation Study (BEST) in 2009 found that the prevalence of osteoporosis in the German population aged over 50 was 14%, and the Scorecard for Osteoporosis in Europe (SCOPE) in 2019 reported that the prevalence in German women was 22.6% and in men was 6.6%.

### Research Methods
The study used an anonymous database of the Institute for Applied Health Research Berlin (InGef), which contains longitudinal data of approximately 8.8 million insured persons of German statutory health insurance companies. A sample of approximately 4 million people was drawn from this database, representing the age and gender distribution of the overall German population. The study subjects included insured persons who were at least 50 years old between 2013 and 2018.

### Main Results
1. **Prevalence of osteoporosis**:
- In 2018, 15.9% of the insured persons in the study population were diagnosed with osteoporosis, and it was estimated that approximately 5.87 million people in the German population aged 50 and above had osteoporosis.
- Women accounted for 81.6% of the affected population.

2. **Osteoporotic fractures**:
- In 2018, approximately 0.7% of the insured persons in the study population had an osteoporotic fracture.
- The proportion of fractures was highest in women aged over 80.

3. **Prescription of osteoporosis - specific drugs**:
- Only 30% of osteoporosis patients or insured persons who had had an osteoporotic fracture received an appropriate drug prescription.
- The treatment gap was more pronounced in men, with only 17% of men receiving a drug prescription, compared to 32.4% in women.

### Conclusions
The prevalence of osteoporosis in Germany is high, but only a small number of patients in need of specific treatment actually receive treatment. This indicates that there are significant gaps in the diagnosis and treatment of osteoporosis, especially more prominent in men. The research results emphasize the importance of improving osteoporosis management, especially in terms of increasing the diagnosis rate and treatment rate.